- Home
- APLT
as 11-15-2024 4:00pm EST
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 971.6M | IPO Year: | 2019 |
| Target Price: | $12.50 | AVG Volume (30 days): | 1.8M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.43 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.79 - $10.62 | Next Earning Date: | 11-07-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | -81.62% | Revenue Growth (next year): | 3169.03% |
Stock Insider Trading Activity of Applied Therapeutics Inc. (APLT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Funtleyder Leslie D. | APLT | Chief Financial Officer | Aug 22 '24 | Sell | $5.83 | 13,530 | $78,879.90 | 277,911 | |
| Perfetti Riccardo | APLT | Chief Medical Officer | Aug 22 '24 | Sell | $5.83 | 22,681 | $132,230.23 | 986,853 |
Latest Applied Therapeutics Inc. News
APLT Breaking Stock News: Dive into APLT Ticker-Specific Updates for Smart Investing
GlobeNewswire
10 days ago
Applied Therapeutics Reports Third Quarter 2024 Financial Results
GlobeNewswire
12 days ago
Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference
Zacks
19 days ago
Applied Therapeutics (APLT) Upgraded to Buy: Here's What You Should Know
Zacks
19 days ago
Is Applied Therapeutics (APLT) Outperforming Other Medical Stocks This Year?
Zacks
a month ago
Are Medical Stocks Lagging Applied Therapeutics (APLT) This Year?
Zacks
2 months ago
Is Applied Therapeutics (APLT) Stock Outpacing Its Medical Peers This Year?
Zacks
2 months ago
All You Need to Know About Applied Therapeutics (APLT) Rating Upgrade to Buy
Zacks
2 months ago
APLT Stock Soars 69% on Positive Update on Galactosemia Drug NDA
Compare APLT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "APLT Applied Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.